Sterling Capital Management’s 89bio ETNB Stock Holding History

Sterling Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,788	Closed	-$85.1K	–	3244
2025 Q3	$85.1K	Buy	5,788 +3,468	+149%	+$35.3K	﹤0.01%	1583
2025 Q2	$22.8K	Buy	2,320 +389	+20%	+$3.22K	﹤0.01%	1748
2025 Q1	$14K	Sell	1,931 -749	-28%	-$6.55K	﹤0.01%	1760
2024 Q4	$21K	Buy	2,680 +2,389	+821%	+$19.7K	﹤0.01%	1859
2024 Q3	$2.15K	Buy	+291	New	+$2.45K	﹤0.01%	2151

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's ETNB Position: Q4 2025 in Review

Sterling Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,788 shares — an estimated $85.1K sold.

Sterling Capital Management first reported a position in ETNB in Q3 2024 and held it in 5 quarters. The position peaked at $85.1K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Sterling Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Sterling Capital Management sold 5,788 89bio shares in Q4 2025, an estimated $85.1K.
Sterling Capital Management first reported a position in 89bio in Q3 2024 and held it in 5 quarters.
Sterling Capital Management's 89bio position peaked at $85.1K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Sterling Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.